SCHEMBL4560927

SCHEMBL4560927

CC(C)(Cc1cc[nH]c1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 1/20 0.44
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 2/20 0.44
BLM P54132 2/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.34
POLB P06746 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP3A4 P08684 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
ALOX15 P16050 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
PTGES2 Q9H7Z7 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5962280 0.76 ESR1 (0.43) CAPN1ALDH1A1KMT2AMEN1SLC6A2
SCHEMBL27656915 0.75 CAPN1 (0.39) CAPN1ALDH1A1KMT2ATRPM8CYP3A4
SCHEMBL517462 0.74 SMN1; SMN2 (0.57) ALDH1A1BLMCYP1A2CYP3A4RECQL
SCHEMBL30599583 0.73 CAPN1 (0.47) CAPN1ALDH1A1KMT2ATRPM8CYP1A2
SCHEMBL28727407 0.72 SMN1; SMN2 (0.55) ALDH1A1BLMCYP1A2CYP3A4RECQL
SCHEMBL28246706 0.72 HIF1A (0.55) ALDH1A1KMT2ABLMCYP1A2CYP3A4
SCHEMBL27925093 0.72 ESR1 (0.56) ALDH1A1KMT2ABLMKDM4EL3MBTL1
SCHEMBL2754652 0.72 TSHR (0.43) CAPN1ALDH1A1KMT2ABLMCYP1A2
SCHEMBL11596247 0.71 BLM (0.67) ALDH1A1KMT2ABLMKDM4ECYP4F2
SCHEMBL6668736 0.71 BLM (0.52) ALDH1A1KMT2ABLMKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102781444-A Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma TAIHO PHARMACEUTICAL CO LTD 2012-11-14 CN claimed
CN-102724981-A Method for predicting treatment effect of chemotherapy on hepatocellular carcinoma patient TAIHO PHARMACEUTICAL CO LTD 2012-10-10 CN claimed
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 EP disclosed
CN-102781444-A Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma TAIHO PHARMACEUTICAL CO LTD 2012-11-14 CN disclosed
CN-102724981-A Method for predicting treatment effect of chemotherapy on hepatocellular carcinoma patient TAIHO PHARMACEUTICAL CO LTD 2012-10-10 CN disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 WO disclosed